Hatch-Waxman 180-Day Exclusivity Does Not Restrict NDA-Holder’s Ability to Sell Generic Version of Patented Drug June 6, 2005Patent, Patent Cases 2005paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post. Login